Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. (ENTA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
enta · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 19 Wall Street analysts in the past 3 months
Buy
19 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$87.00
Consensus
$48.20
+335.4% upside
Low
$20.00
Median: $54 · Last Close: $11.07
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$48.20
335.4% upside
High Target
$87
685.9%
Low Target
$20
80.7%
Current Price
$11.07
as of today
Based on analyst price targets, the ENTA stock price prediction for the next 12 months ranges from $20 to $87. The consensus ENTA price forecast of $48.20 implies 335.4% upside from the current price of $11.07.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.52 | ↓ 5.00% |
1-day model range: $10.46–$10.57. Peak: $10.57 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ENTA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-01 | Jefferies | Upgrade ↑ | Hold→Buy |
| 2025-09-30 | WestPark Capital | Maintains | Buy→Buy |
| 2025-09-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-08-12 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-06-03 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-05-14 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-02-11 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-02-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Enanta Pharmaceuticals, Inc. (ENTA) stock. Of the recent 112 rating actions, 7 were upgrades and 10 were downgrades. 19 analysts currently cover ENTA.
Analyst Recommendation Trends
ENTA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$68M
↑ 1.1% YoY
Revenue Next Year
$65M
↓ 4.5% YoY
EPS This Year
$-2.28
EPS Next Year
$-1.75
↓ 23.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ENTA EPS of $-2.28 for the current fiscal year, based on estimates from 4 analysts. The ENTA revenue forecast is $68M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ENTA stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ENTA price target is $48.20 (+335.4% upside), with an analyst consensus of Buy.
The ENTA short-term stock prediction for tomorrow is $10.52 (-5.00%).
Enanta Pharmaceuticals, Inc. trades on NASDAQ under the ticker ENTA. The ENTA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 74% of covering analysts.
Frequently asked questions
ENTA forecast · 8 questionsAccording to 19 Wall Street analysts, the average 12-month ENTA price target is $48.20, with a high forecast of $87.00 and a low of $20.00. The median price target is shown in the chart above when available. This implies +335.4% potential upside from the current price of $11.07.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.